Celltex Therapeutics
Celltex Therapeutics is a Houston-based biotechnology company that isolates, culture-expands, and cryopreserves autologous adipose-derived mesenchymal stem cells in an FDA cGMP-compliant lab, serving individuals with chronic, autoimmune, and degenerative conditions through stem cell banking and therapy administered in Cancun, Mexico.
- Company typePrivate
- Founded2011
- HeadquartersHouston, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Celltex Therapeutics does
Celltex Therapeutics Corporation is a Houston, Texas-based biotechnology company founded in 2011 by David Eller and Dr. Stanley Jones that operates an FDA-registered, cGMP-compliant laboratory specializing in autologous adult adipose-derived Mesenchymal Stem Cell (MSC) banking and therapy. Using a proprietary process, the company isolates, culture-expands, and cryopreserves hundreds of millions of a client's own MSCs from a single fat-tissue sample, storing them at -300°F for lifetime therapeutic use. Therapy administration is delivered at Hospital Galenia in Cancun, Mexico under COFEPRIS oversight through Celltex Mexico, its wholly-owned subsidiary, creating a medical-tourism model for US clients.
The company markets two integrated offerings: a one-time Adult Stem Cell Banking service (with ongoing cryogenic storage fees) and an MSC Therapy service delivered via IV infusion, intraarticular, intradiscal, intrathecal, intranasal, intradermal, or nebulizer routes by licensed physicians. Celltex differentiates on dose scale (approximately 20,000x larger than same-day stem-cell therapies), a 10,000+ therapy track record with no severe adverse events reported, and reported clinical outcomes (e.g., 83% osteoarthritis symptom improvement, 100% inflammatory arthritis respondents reporting improvement). Target customers are individuals with chronic, autoimmune, neurological, orthopedic, and degenerative conditions, plus a secondary wellness/longevity segment.
The go-to-market is direct-to-consumer with a sales-assisted layer: a website funnel, free no-obligation assessment questionnaires, educational webinars, client testimonials, and a medical-professional partner program drive enrollment, while a Client Services team coordinates medical reviews and logistics. Revenue is generated through upfront banking fees, recurring storage subscriptions, and per-episode therapy charges, though pricing is not publicly disclosed. Celltex is a privately held company with 11–50 employees, a single $34M funding round disclosed in 2012, and no public financial reporting.
Celltex Therapeutics firmographics
Firmographics- Name
- Celltex Therapeutics
- Legal name
- Celltex Therapeutics Corporation
- Website
- https://celltexbank.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Celltex Therapeutics is a Houston-based biotechnology company that isolates, culture-expands, and cryopreserves autologous adipose-derived mesenchymal stem cells in an FDA cGMP-compliant lab, serving individuals with chronic, autoimmune, and degenerative conditions through stem cell banking and therapy administered in Cancun, Mexico.
- Ownership category
- akta.pro rank
Celltex Therapeutics industry classification
Industry- Product category
- Regenerative Medicine Services
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical and Medicine Manufacturing (3254), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Blood and Organ Banks (621991)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Cell Therapy Developers (Autologous) (HLAAABAA)
- akta.pro secondary industries
- Stem Cell–Based Regenerative Therapies (HLAAAGAA), Cell Therapy Manufacturing Services (GMP, autologous/allogeneic) (HLAAAKAC), Cell Therapy Manufacturing Platforms & Automation (closed systems, bioreactors, fill-finish) (HLAAABAG), Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables) (HLAAABAH), Bone Marrow & Stem Cell Transplant (BMT/HSCT) (HLAKAFAI)
Keywords
Where Celltex Therapeutics is headquartered
LocationHeadquarters
- HQ city
- Houston
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Celltex Therapeutics business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others
Revenue model
- Adult Stem Cell Banking Services: One-time adipose tissue extraction followed by MSC isolation, culture expansion, and cryopreservation for lifetime storage. Clients pay for the initial banking process and ongoing storage fees.
- Stem Cell Therapy Services: When therapy is needed, stored MSCs are thawed and culture-expanded to therapeutic dose, then administered by licensed physicians at Hospital Galenia in Cancun, Mexico.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Celltex Therapeutics product offering
Product offeringCore offering
Celltex Therapeutics provides adult stem cell banking and therapy services using its proprietary technology to isolate, culture-expand, and cryopreserve autologous adipose-derived Mesenchymal Stem Cells (MSCs). From a single fat tissue sample, the company produces hundreds of millions of clinical-grade MSCs stored in its FDA cGMP-compliant Houston laboratory for lifetime therapeutic use. Therapy is administered by licensed physicians at Hospital Galenia in Cancun, Mexico, through multiple delivery routes including IV infusion and targeted injections.
Product overview
Celltex Therapeutics offers a unified adult stem cell banking and therapy service centered on its proprietary Mesenchymal Stem Cell (MSC) technology. The core offering consists of Adult Stem Cell Banking, which isolates, expands, and cryopreserves a client's own adipose-derived MSCs into hundreds of millions of clinical-grade cells stored for lifetime therapeutic use. This is complemented by MSC Therapy, where banked cells are administered through various routes (IV infusion, targeted injections) by licensed physicians. The company's competitive differentiator is its high-dose culture expansion process, which yields approximately 20,000x more MSCs than same-day stem cell therapies. Client Services provides ongoing support throughout the process.
Differentiator
Problem solved
Functional benefit
Products and services
- Adult Stem Cell Banking Celltex's proprietary process for isolating, culturing, and cryopreserving autologous adipose-derived Mesenchymal Stem Cells (MSCs) from a single fat tissue sample to create a lifetime stem cell bank. Cells are stored at -300°F in FDA cGMP-compliant Houston laboratory with ISO Class 7 clean room.
- MSC Therapy Therapeutic application of banked mesenchymal stem cells through various administration routes (IV infusion, intraarticular injection, intradiscal injection, intrathecal injection, intradermal injection, intranasal infusion, nebulizer infusion) performed by licensed physicians at Hospital Galenia in Cancun, Mexico. Treats conditions including autoimmune diseases, vascular diseases, degenerative diseases, and orthopedic conditions.
Quantifiable outcome
- Over 10,000 stem cell therapies administered with no severe adverse events
- +5 more outcomes
Companies that use Celltex Therapeutics
Customer profileNamed customers7 records
Segments5 records
Ideal customer profiles3 records
Celltex Therapeutics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Celltex Therapeutics partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Hospital GaleniacoreHospital Galenia in Cancun, Quintana Roo, Mexico is the primary therapy administration site for Celltex clients. The hospital operates under COFEPRIS (Federal Commission for Protection against Sanitary Risk), Mexico's equivalent of the FDA. Celltex Mexico's team of administering physicians includes specialists in orthopedic surgery, neurosurgery, emergency medicine, and anesthesiology who perform various MSC injection and infusion methods at the hospital.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Celltex Therapeutics competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Celltex Therapeutics social profiles
Digital presenceCelltex Therapeutics compliance and trust
Trust signalCompliance3 records
Celltex Therapeutics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Celltex Therapeutics leadership team
Management profileNumber of profiles
Profiles6 records
Celltex Therapeutics subsidiaries and ownership
Company hierarchySubsidiaries1 record
Celltex Therapeutics funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Celltex Therapeutics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Celltex Therapeutics
What does Celltex Therapeutics do?
Celltex Therapeutics provides adult stem cell banking and therapy services using its proprietary technology to isolate, culture-expand, and cryopreserve autologous adipose-derived Mesenchymal Stem Cells (MSCs). From a single fat tissue sample, the company produces hundreds of millions of clinical-grade MSCs stored in its FDA cGMP-compliant Houston laboratory for lifetime therapeutic use. Therapy is administered by licensed physicians at Hospital Galenia in Cancun, Mexico, through multiple delivery routes including IV infusion and targeted injections.
Is Celltex Therapeutics a public or private company?
Celltex Therapeutics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Celltex Therapeutics founded?
Celltex Therapeutics was founded in 2011. It employs 11 to 50 people.
Where is Celltex Therapeutics based?
Celltex Therapeutics is headquartered in Houston, United States, in the North America region.
How does Celltex Therapeutics make money?
Two revenue lines are on record. Adult Stem Cell Banking Services are the primary driver. The others are stem Cell Therapy Services.
Does Celltex Therapeutics have an API?
No public API is recorded for Celltex Therapeutics.
What industry is Celltex Therapeutics in?
Celltex Therapeutics's product category is Regenerative Medicine Services. Its primary akta.pro industry code is HLAAABAA, Cell Therapy Developers (Autologous), with a secondary code of HLAAAGAA, Stem Cell–Based Regenerative Therapies. Its NAICS code is 325414 and its SIC code is 2836.